We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Arachidonic Acid Stimulates Cancer Growth

By Biotechdaily staff writers
Posted on 16 Feb 2006
Researchers have found that arachidonic acid, an omega-6 fatty acid, stimulated the growth of tumor cells by activating the metabolic pathway leading to prostaglandin synthesis and translocation to the nucleus of nuclear factor-kappaB (NF-kappaB).

Investigators at the San Francisco Veterans Administration Medical Center (CA, USA) added arachidonic acid to human prostate tumor cells growing in tissue culture. More...
They found that this prompted the cells to grow at a rate nearly double that of control cells that did not receive arachidonic acid.

Analysis using gene chip technology showed that arachidonic acid induced 11 genes that were regulated by NF-kappaB. Within five minutes of addition of arachidonic acid prostaglandin E2 (PGE2) synthesis was increased, and analysis of upstream signal transduction showed that phosphatidylinositol 3-kinase (PI3K) was significantly activated. These events were followed by activation of Akt at 30 minutes, when a significant three-fold increase in translocation of NF-kappaB to the nucleus was seen. Interruption of the pathway by treatment with either a COX-2 inhibitor or with a PI3K inhibitor reversed the stimulatory effect of arachidonic acid. These findings were published in the February 1, 2006, issue of Cancer Research.

Senior author Dr. Mille Hughes-Fulford, director of the Laboratory of Cell Growth at the San Francisco Veterans Administration Medical Center, said, "Investigating the reasons for this rapid growth, we discovered that the omega-6 was turning on a dozen inflammatory genes that are known to be important in cancer. We then asked what was turning on those genes, and found that omega-6 fatty acids actually turn on a signal pathway called PI3-kinase that is known to be a key player in cancer. I am not a physician, and do not tell people how to eat, but in my own home I use only canola oil and olive oil. We do not eat deep-fried foods.”



Related Links:
San Francisco Veterans Administration Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.